Company Overview - IDEX Corporation (IEX) is a global leader in applied solutions, engineering and manufacturing critical components for essential industrial functions, with a market capitalization of approximately $13.4 billion [1] Earnings Expectations - The upcoming fiscal 2025 fourth-quarter earnings release is scheduled for February 3, with Wall Street expecting diluted EPS of $2.04, unchanged from the previous year [2] - Analysts project fiscal 2025 diluted EPS to remain at $7.89, with a forecasted increase of 5.3% for fiscal year 2026, raising EPS to $8.31 [2] Stock Performance - IEX stock has underperformed compared to broader benchmarks, declining 12.7% over the past 52 weeks, while showing a slight increase of 1.6% year-to-date [3] - In contrast, the S&P 500 Index rose by 16.2% over the same period, and the State Street Industrial Select Sector SPDR ETF (XLI) increased by 20.4% in the last year [3] Recent Financial Results - IDEX reported a significant positive catalyst on October 29, 2025, with a 3.9% intraday stock jump following its fiscal Q3 2025 earnings release [4] - Revenue for the quarter increased by 10.1% year-over-year to $878.7 million, surpassing analyst estimates of $861.1 million [4] - Adjusted EPS rose by 6.8% from the previous year to $2.03, exceeding expectations of $1.93 [4] Management Insights - Management attributed the strong performance to momentum in Health & Science Technologies and solid demand from data centers, municipal water projects, and pharmaceutical customers [5] - CEO Eric Ashleman highlighted the "8020 philosophy," which has sharpened operational focus, accelerated acquisition integration, and enhanced contributions from material science and intelligent water platforms [5]

Company Overview - IDEX is a manufacturer of highly engineered components, providing innovative solutions for challenging applications[8] - In 2024, IDEX reported revenue of $3.3 billion, adjusted EBITDA of $874 million, and free cash flow of $603 million[10] - The company operates through three segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP)[9, 10] Segment Performance (2024) - Health & Science Technologies (HST) had sales of $1.3 billion, representing approximately 39% of total segment sales, with an adjusted EBITDA margin of 27%[9, 22] - Fluid & Metering Technologies (FMT) had sales of $1.233 billion with an adjusted EBITDA margin of 33%[30] - Fire & Safety/Diversified Products (FSDP) had sales of $0.7 billion, about 23% of total segment sales, with an adjusted EBITDA margin of 29%[9, 22] Financial Performance & Growth - IDEX deployed approximately $3 billion in capital on M&A in the last 5 years[41, 66] - The company is targeting higher-growth markets and accelerating commercial & operational integration across platforms[37] - In 2024, the adjusted diluted EPS attributable to IDEX was $7.89[58, 74] Financial Flexibility - In 2024, the free cash flow was $603 million, representing a 101% conversion rate[10, 60, 61]